Snake Bite
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Mission TherapeuticsUK - Cambridge
1 programHistory, examination, bite documentation, SSS scoring,Baseline labs as per institutional protocolN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2025
2026
2027
Mission TherapeuticsHistory, examination, bite documentation, SSS scoring,Baseline labs as per institutional protocol
Clinical Trials (1)
Total enrollment: 220 patients across 1 trials
NCT07079137Mission TherapeuticsHistory, examination, bite documentation, SSS scoring,Baseline labs as per institutional protocol
A Prospective Observational Study to Determine the Predictive Accuracy of Snakebite Severity Score (SSS) in Identifying Syndrome-Specific Core Outcome Parameters Amongst Envenomated Patients Presenting to the Emergency Department.
Start: Jul 2025Est. completion: Jun 2027220 patients
N/ANot Yet Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space